QPS Netherlands B.V.
- Address
- Hanzeplein 1, 9713 GZ Groningen, The Netherlands
Hemic and Lymphatic Diseases
The research at QPS Netherlands B.V. focuses on coagulation reversal for patients on DOACs who experience bleeding or need rapid anticoagulation cessation before urgent surgery. The work aims to improve emergency management and evaluate new therapeutic options for restoring normal clotting.
- Evaluation of reversal agents in emergency settings
- Safety profiling in healthy volunteers
- Pharmacokinetic assessment of novel suspension capsules
This program underscores the site’s commitment to advancing care for bleeding disorders while supporting innovative drug development.
Nervous System Diseases
At the Clinical Pharmacology department, investigators are studying Parkinson's disease through the investigation of NT-0796. The primary goal is to assess safety, tolerability, and potential therapeutic benefit for patients with this neurodegenerative condition.
- Assessment of motor symptom improvement
- Biomarker analysis for disease progression
- Dose escalation safety studies
These efforts reflect the site’s dedication to delivering new treatment options for neurological disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in QPS Netherlands B.V.
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of NT-0796 in Healthy Volunteers and Individuals with Parkinson's Disease | Nodthera Limited | Phase I | Not Recruiting | Apr 2023 | Dec 2023 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Lidocaine Hydrochloride | 1 | Unknown | 2023-04-12 | 2023-04-12 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.